Skip to content
Sunday 13 September 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,650.44
+0.39%
DAX
25,568.56
+0.82%
CAC 40
8,179.77
+0.78%
STOXX 50
6,325.13
+0.90%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Wednesday 05 February 2020 3:25 pm  |  Updated:  Wednesday 05 February 2020 3:31 pm

FTSE 100 and oil prices gain on reports of coronavirus vaccine ‘breakthrough’

By: Harry Robertson

Add as a preferred source on Google
FTSE 100 slips on coronavirus caution
Global markets, including the FTSE 100, have been rattled by the coronavirus outbreak

The FTSE 100 and European stocks have staged a comeback after opening in the red, following reports that scientists may have found a breakthrough in developing a possible coronavirus treatment.

Europe’s abrupt about-turn followed an overnight rise in Asian markets, where traders were buoyed by the prospect of additional stimulus from the Chinese government.

Britain’s blue-chip index had risen 0.6 per cent by 3pm. In Germany, the Dax climbed 1.3 per cent, while in France the CAC 40 was 0.9 per cent higher.

Coronavirus ‘breakthrough’ helps FTSE 100

Reuters reported that cheerier traders were citing a Chinese TV report that a Chinese university research team has found an effective drug to treat people with coronavirus.

Sky News also reported that scientists at Imperial College London said they have made a significant breakthrough in reducing part of the normal development time of a possible vaccine from “two to three years to just 13 days”.

Oil prices also jumped. Brent crude surged three per cent to $55.60 per barrel and WTI leaped 2.4 per cent to $50.81.

It has been a wild few weeks for investors as coronavirus has ripped through China and cases have spread around the world.

The virus, which originated in the Chinese city of Wuhan, has now killed 490 people, with 65 deaths reported yesterday. The total number of infections has risen to more than 24,000.

Two people have died outside mainland China: a 39-year-old man in Hong Kong and a man in the Philippines.

Read more

FTSE 100 creeps closer to record high as investors dodge AI turmoil

The FTSE 100 enjoyed a 3-year record rally in the third quarter.

Asian stocks boosted by hopes of China stimulus

Beijing has pumped billions of dollars into its financial system this week in a bid to limit the economic fallout from the coronavirus.

China’s central bank is likely to cut key interest rates on 20 February and lower banks’ reserve requirements in the coming weeks. That will see it release more cash into the economy, sources told Reuters.

“Shares in Asia rose on the hopes of fresh Chinese stimulus, but gains were capped by data showing Chinese service sector activity hit a three-month low in January,” said Jasper Lawler of London Capital Group.

Overnight the Chinese Shanghai composite index finished 1.3 per cent higher as it continued its recovery from a 7.7 per cent plunge on Monday, its first day of trading since 23 January.

Hong Kong’s Hang Seng ended the day 0.2 per cent higher, while Japan’s Nikkei finished up one per cent.

Jing Sima, China strategist at investment researcher BCA Research, said there were some positive signs that the virus was being adequately tackled.

“The economic impact on China from the outbreak will be large, but manufacturing activities in the majority of Chinese cities should resume by the end of February,” she said.

Sima said BCA maintains “an overweight stance on Chinese stocks” as it believes “China’s budding economic recovery will be delayed, but not prevented, by the crisis”.

Chris Scicluna of Daiwa Capital Markets said that although “uncertainty prevails over the true scale of the epidemic”, the last two days of stock market rises show that investors think “the impact will be contained and short-lived”.

Read more

ACCELQ Named ‘AI-Based Engineering Solution of the Year’ in the 9th Annual AI Breakthrough Awards 2026

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Markets & Economics

Categories

  • Markets

Trending Articles

  • Wetherspoon boss: ‘Not up to Burnham’ to choose who is on the high street 

  • Primark sales slip as owner dresses up retailer for demerger

  • Badger Beer maker Hall & Woodhouse doubles profit ahead of tie-up with James May

  • Crystal Palace owner Blitzer part of £1bn mega stadium redevelopment

  • Barclays faces legal scrutiny over role in £90m ‘Ponzi scheme within a Ponzi scheme’

More from Morning Wire

  • FTSE 100 creeps closer to record high as investors dodge AI turmoil

    Markets
    The FTSE 100 enjoyed a 3-year record rally in the third quarter.
  • ACCELQ Named ‘AI-Based Engineering Solution of the Year’ in the 9th Annual AI Breakthrough Awards 2026

    Business Wire
  • As it happened: FTSE 100 falls but Nasdaq soars after Nvidia sales boom

    FTSE 100 Live
    Smiling man with gray hair and glasses in a dark suit and blue tie, speaking at an event.
  • As it happened: Antofagasta leads FTSE 100 rally; oil falls as US-Iran deal ‘close’

    FTSE 100 Live
    FTSE 100 stocks rise as Brent crude oil prices jump 1.8% to $104.98 amid Strait of Hormuz tensions and Trumps Iran stance
  • As it happened: FTSE 100 drops as Antofagasta prompts miner sell-off; oil prices cool

    FTSE 100 Live
    Glencore floated on the London Stock Exchange in 2011 and is one of the largest members of the FTSE 100.
  • Aviva profits jump following Direct Line acquisition

    Insurance
    Aviva's deal to buy Direct Line was agreed in March
  • As it happened: FTSE 100 climbs as markets digest Bessent buyback

    Markets
    Scott Bessent, a man with gray hair and glasses, wearing a blue suit and striped tie, looking to the side.
  • Astrazeneca explores $400bn megadeal with US rival 

    Markets
    AstraZeneca building exterior with logo, glass facade, UK flag, and wildflowers in foreground.
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook